- Home
- QTRX vs CRVS Comparison
QTRX vs CRVS Comparison
Compare QTRX & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- CRVS
- Stock Information
- Founded
- QTRX 2007
- CRVS 2014
- Country
- QTRX United States
- CRVS United States
- Employees
- QTRX N/A
- CRVS N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- QTRX Industrials
- CRVS Health Care
- Exchange
- QTRX Nasdaq
- CRVS Nasdaq
- Market Cap
- QTRX 201.7M
- CRVS 206.5M
- IPO Year
- QTRX 2017
- CRVS 2016
- Fundamental
- Price
- QTRX $5.15
- CRVS $3.24
- Analyst Decision
- QTRX Strong Buy
- CRVS Strong Buy
- Analyst Count
- QTRX 4
- CRVS 3
- Target Price
- QTRX $18.25
- CRVS $15.67
- AVG Volume (30 Days)
- QTRX 764.8K
- CRVS 884.2K
- Earning Date
- QTRX 05-06-2025
- CRVS 05-05-2025
- Dividend Yield
- QTRX N/A
- CRVS N/A
- EPS Growth
- QTRX N/A
- CRVS N/A
- EPS
- QTRX N/A
- CRVS N/A
- Revenue
- QTRX $137,421,000.00
- CRVS N/A
- Revenue This Year
- QTRX $5.22
- CRVS N/A
- Revenue Next Year
- QTRX $15.31
- CRVS N/A
- P/E Ratio
- QTRX N/A
- CRVS N/A
- Revenue Growth
- QTRX 12.30
- CRVS N/A
- 52 Week Low
- QTRX $4.67
- CRVS $1.30
- 52 Week High
- QTRX $19.18
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- QTRX 36.29
- CRVS 42.22
- Support Level
- QTRX $5.03
- CRVS $2.80
- Resistance Level
- QTRX $5.73
- CRVS $3.37
- Average True Range (ATR)
- QTRX 0.52
- CRVS 0.27
- MACD
- QTRX -0.02
- CRVS 0.07
- Stochastic Oscillator
- QTRX 21.43
- CRVS 78.65
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).